Why did Novo Nordisk stock today fall so sharply?

The stock slid after a head-to-head study showed Novo Nordisk CagriSema underperforming Eli Lilly tirzepatide on key weight-loss measures. Investors quickly repriced long-term market share and growth assumptions, driving a broad selloff across Danish equities and adding pressure on the krone. Spreads widened as liquidity thinned during the move.

How does this affect investors in Germany specifically?

German investors often hold the stock via UCITS funds, healthcare ETFs, or OMX Copenhagen 25 trackers. Returns in euros can diverge from local returns due to moves in the Danish krone or U.S. dollar. Consider limit orders, smaller sizing, and euro-hedged options to manage volatility and currency translation risk.

What are the current analyst views after the drop?

The Street looks mixed: 5 Buy, 15 Hold, and 4 Sell ratings, implying a Hold consensus. Many will wait for clearer guidance on CagriSema strategy and timelines before changing views. Technicals are oversold, so short-term bounces are possible, but conviction hinges on new data and management updates.

What could help Novo Nordisk stock today recover?

Clear communication on next steps for CagriSema, confirmation of resilient prescription trends, and signs that competitors are not widening the lead could support a rebound. Stabilization in OMX Copenhagen 25 and the krone would help risk appetite. Technical improvement from oversold levels may also attract tactical buyers.

Global Market Insights

NVO Stock Today: February 24 – CagriSema Miss Triggers 17% Plunge

ByHuzaifa Zahoor February 25, 2026February 25, 2026

Novo Nordisk stock today fell sharply after its CagriSema weight-loss therapy underperformed Eli Lilly’s tirzepatide in a head-to-head study. The news sparked a broad selloff in Danish equities and pressure on the krone, with spillovers that Germany-based investors are watching closely. The ADR NVO and Copenhagen listing both reflected the shock. We break down what happened, why it matters for portfolios in Germany, and which signals could point to stabilization or further downside in the weeks ahead.